Načítá se...
Regulatory and policy tools to address unproven stem cell interventions in Canada: the need for action
BACKGROUND: The marketing of unproven direct-to-consumer stem cell interventions is becoming widespread in Canada. There is little evidence supporting their use and they have been associated with a range of harms. Canada has been slower to act against clinics offering these interventions than other...
Uloženo v:
| Vydáno v: | BMC Med Ethics |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6683337/ https://ncbi.nlm.nih.gov/pubmed/31383026 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12910-019-0388-4 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|